James Lanthier

Toronto-based Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) will be acquired by Japan-based Otsuka Pharmaceutical Co. through its American subsidiary in an all-cash transaction valued...

Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) filed patent applications in multiple countries for a group of compounds called “Family 6” that are not hallucinogenic...

Mindset Pharma Inc. (CSE: MSET | FSE: 9DF | OTCQB: MSSTF) today issued a letter to shareholders from James Lanthier, Chief Executive Officer of Mindset....

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) CEO James Lanthier speaks to Proactive's Stephen Gunnion after the company announced it had chosen...

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) CEO James Lanthier speaks to Proactive's Stephen Gunnion after the company announced it had chosen a ...

In this episode of the podcast, Joe Moore interviews the CEO of Mindset Pharma, James Lanthier. Mindset Pharma is a 3-year old biotechnology company built...

In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer,...

Mindset Pharma CEO James Lanthier said the collaboration would profile and build the company's understanding of the observed superiority of...

There are 20,000 drugs in active development globally. More novel drugs made their market debut in 2020 than in any other year, with 82 released...

As the industry matures, there are clear leaders in the pack of psychedelics companies who are positioned to continue driving industry development. Compass Pathways, Atai...